The colorectal microRNAome.
By Jordan M. Cummins, Yiping He, R. Leary, R. Pagliarini, L. Diaz, T. Sjoblom, Omer Barad, Z. Bentwich, A. Szafranska, E. Labourier and 6 more. Proceedings of the National Academy of Sciences of the United States of America, 2006
999 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/e8e2ae9237eee41e504b5b1ef115bb3c74fb3847
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- David P. Bartel
- Carlo Maria Croce
- George A. Calin
- E. Miska
- Thomas Tuschl
- Gregory J. Hannon
- Gordon K. Smyth
- Peter S. Linsley
In Molecular Biology
- David P. Bartel
- Carlo Maria Croce
- Thomas Tuschl
- George A. Calin
- E. Miska
- Gregory J. Hannon
- Phillip D. Zamore
- Gordon K. Smyth
Citations in the corpus
- Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. (2008, methodology): “2) is commonly reported in miRNA cloning studies but generally dismissed with either the sequence matching the miRBase record or the most frequently observed isomiR chosen as a reference sequence (Cummins et al. 2006; Ruby et al. 2006; Landgraf et al. 2007).”
- MicroRNA expression profiling in prostate cancer. (2007, result): “The data agree with the previously published miRNA profiling studies, most of which have shown downregulation of miRNAs to be more common than up-regulation in cancer (9, 10 , 16, 29).”
- miR-19 is a key oncogenic component of mir-17-92. (2009, methodology): “…luciferase constructs that contain either the wild-type or the mutated PTEN 3 9 UTR were each transfected into the Dicer-deficient Hct116 cells (Cummins et al. 2006), together with a Renilla luciferase construct for normalization control, and 50 nM miRNA mimics for mir-17 , mir-18 , miR-19b ,…”
- A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence (2008, positive): “To confirm these results, we transfected wild-type and fully mutated Dicer into two cell lines—the wild-type HCT116 human colorectal cancer cell line and a version of this cell line with targeted disruption of Dicer exon 5, which has the effect of lowering total intracellular mature miRNA concentrat”
- Serum MicroRNAs Are Promising Novel Biomarkers (2008, background): “Although the total number of microRNAs remains controversial [4,10,11] and the roles of specific microRNAs are only beginning to be defined, microRNA expression analyses indicate that diverse tumors display microRNA expression profiles (for mature and/or precursor microRNAs) significantly different ”
- A mammalian microRNA expression atlas based on small RNA library sequencing. (2007, methodology): “deep-sequencing technologies (Berezikov et al., 2006a, 2006b; Cummins et al., 2006; Kloosterman et al., 2006a) or specialized small RNA isolation and cloning procedures (Bentwich et al.”
- mir-29 regulates Mcl-1 protein expression and apoptosis (2007, background): “For example, mir-29 is also downregulated in aggressive chronic lymphocytic leukemia, colon and breast cancer (Calin et al., 2005; Cummins et al., 2006; Yanaihara et al., 2006).”
- Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression (2007, methodology): “These lines have homozygous disruption of the Dicer helicase domain and show reduced levels of many endogenous miRNAs (15).”
- Human tRNA-derived small RNAs in the global regulation of RNA silencing. (2010, background): “Alternatively, the induced species may be the result of a catalytic activity of Argonautes upstream of target cleavage in the RNAi pathway, as has been suggested for Argonaute 2 (Diederichs and Haber 2007; O'Carroll et al. 2007 ).”
- MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype (2007, background): “Subsequently, a number of studies, using a range of techniques, including miRNA cloning, quantitative PCR, microarrays and bead-based flow cytometric miRNA expression profiling [53-56], demonstrated that miRNA expression is deregulated in many human cancers.”
- Moderated statistical tests for assessing differences in tag abundance (2007, background): “Availability: An R package can be accessed from http://bioinf.wehi. edu.au/resources/ Contact: smyth@wehi.edu.au Supplementary information: http://bioinf.wehi.edu.au/resources/”